TP53 and cancer: Studies in mouse models and cancer cell lines suggest that a deficiency of some RPs can destabilize ribosome assembly, leading to the accumulation of free RPs, including RPL5 and RPL11, which sequester MDM2 and inhibit its ubiquitin ligase activity that promotes TP53 degradation (24, 25).